J&J gets FDA approval for smaller Cypher stent

09/21/2009 | NYTimes.com

Johnson & Johnson received FDA approval for a 2.25-millimeter version of its Cypher drug-eluting stent, designed to treat smaller blood vessels. The agency granted approval after a study showed that the device was more effective than bare-metal stents in keeping small blood vessels from reclogging.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD